Austin, Texas, October 7th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based ...

Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...

Austin, Texas, September 24th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its ...

Session: Advances in Oncology Panel Presenter: Walter Klemp, Chairman and Chief Executive Officer of Moleculin Date/time: Wednesday, October 14, 2026, from 9:00 - 10:00 a.m. ET Location: NYY Room at ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology Market - Therapeutic Innovations & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. Global Biotechnology ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus on plants at the molecular level, paving the way for next-generation crop ...

The global white biotechnology market is forecast to expand from USD 334.755 billion in 2025 to USD 541.097 billion by 2031, representing a compound annual growth rate of 8.33%. Market growth is being ...

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

Oncolytics Biotech remains in focus as the cancer-focused biotech advances its oncolytic virus pelareorep through multiple clinical trials, including breast and gastrointestinal cancer studies, ...

Advances FDA-Aligned Methods To Reduce Animal Testing. VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.

(MENAFN- GlobeNewsWire - Nasdaq) Demand for low-carbon biofuels, bioplastics, chemicals and enzymes is rising, fueled by policy and biotech advances. Asia-Pacific offers strong scaling opportunities.